Oral and perioral herpes simplex virus infections are commonly seen and managed by the dental practitioner. Many topical and oral antiviral agents are available in Israel. However, only a few regimens are based on solid evidence. The purpose of this study was to review the mode of action of antiviral agents and to present therapeutic regimens supported by randomized control trials.
|Pages (from-to)||6-13, 65|
|Journal||Refuat Hapeh Vehashinayim|
|State||Published - Apr 2006|